Perry M Kirkham

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Top Venues

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Wonkyung Oh, Alyssa Min Jung Kim, Deepika Dhawan, Perry M Kirkham, Raluca Ostafe, Jackeline Franco, Uma K Aryal, Robert H Carnahan, Valery Patsekin, J Paul Robinson, Deborah W Knapp, Seung-Oe Lim
Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans. Cancer research communications 3 (5) (2023)
Wonkyung Oh, Alyssa Min Jung Kim, Deepika Dhawan, Perry M Kirkham, Raluca Ostafe, Jackeline Franco, Uma K Aryal, Robert H Carnahan, Valery Patsekin, J Paul Robinson, Deborah W Knapp, Seung-Oe Lim
Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans. Cancer research communications 3 (5) (2023)
Wonkyung Oh, Alyssa Min Jung Kim, Deepika Dhawan, Perry M Kirkham, Raluca Ostafe, Jackeline Franco, Uma K Aryal, Robert H Carnahan, Valery Patsekin, J Paul Robinson, Deborah W Knapp, Seung-Oe Lim
Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans. Cancer research communications 3 (5) (2023)
Wonkyung Oh, Alyssa Min Jung Kim, Deepika Dhawan, Perry M Kirkham, Raluca Ostafe, Jackeline Franco, Uma K Aryal, Robert H Carnahan, Valery Patsekin, J Paul Robinson, Deborah W Knapp, Seung-Oe Lim
Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans. Cancer research communications 3 (5) (2023)
Wonkyung Oh, Alyssa Min Jung Kim, Deepika Dhawan, Perry M Kirkham, Raluca Ostafe, Jackeline Franco, Uma K Aryal, Robert H Carnahan, Valery Patsekin, J Paul Robinson, Deborah W Knapp, Seung-Oe Lim
Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans. Cancer research communications 3 (5) (2023)